Health News Archive - January 05, 2009
Stopping a molecule may stop metastasis -- the ability of cancer cells to spread to distant sites -- British scientists suggest. Study leader Marco Falasca of Barts and The London School of Medicine and Dentistry says stopping metastasis stops cancer from killing people -- and this discovery could lead to metastasis-blocking drugs. The researchers investigated the role of the enzyme in cell invasion and find it is required for breast cancer cell invasion activation of the protein Rac1.
SHENZHEN, China, Jan. 5 /PRNewswire-Asia-FirstCall/ -- China Nepstar Chain Drugstore Ltd.
MCLEAN, Va., Jan. 5 /PRNewswire/ -- Dr. Siegal's Direct Nutritionals, LLC, the exclusive worldwide distributor of the 34 year old Dr.
SHENZHEN, China, Jan. 5 /PRNewswire-Asia-FirstCall/ -- China Nepstar Chain Drugstore Ltd. (NYSE: NPD) ("Nepstar" or "the Company"), the largest retail drugstore chain in China based on the number of directly operated stores, today announced the appointment of Mr.
SAN JOSE, Calif., Jan. 5 /PRNewswire/ -- Women undergoing in vitro fertilization (IVF) require progesterone medication to help support early pregnancy, but the intramuscular injections for some forms of this medication can be painful for patients.
OAKBROOK TERRACE, Ill., Jan.
LUFKIN, Texas, Jan. 5 /PRNewswire-FirstCall/ -- The Ensign Group, Inc. (Nasdaq: ENSG), announced today that it has acquired Southland Healthcare Center, a 150-bed skilled nursing facility in Lufkin, Texas. The transfer was effective January 1, 2009.
SAN LUIS OBISPO, Calif., Jan. 5 /PRNewswire-FirstCall/ -- The Ensign Group, Inc. (Nasdaq: ENSG), announced today that it has acquired Cabrillo Care Center, a 156-bed skilled nursing facility in San Luis Obispo, California. The transfer was effective January 1, 2009.
Lumenis announces 510(k) approval for the new AcuPulse CO2 Laser with SurgiTouch Automation System SANTA CLARA, Calif., Jan.
BOSTON, Jan. 5 /PRNewswire-FirstCall/ -- Perceptive Informatics, the industry's leading eClinical solutions provider and a subsidiary of PAREXEL International Corporation (Nasdaq: PRXL), today announced that it has entered into a license agreement with the EuroQoL Group.